BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 8137248)

  • 1. Antiestrogenic effects of all-trans-retinoic acid and 1,25-dihydroxyvitamin D3 in breast cancer cells occur at the estrogen response element level but through different molecular mechanisms.
    Demirpence E; Balaguer P; Trousse F; Nicolas JC; Pons M; Gagne D
    Cancer Res; 1994 Mar; 54(6):1458-64. PubMed ID: 8137248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel estrogenic action of the pesticide residue beta-hexachlorocyclohexane in human breast cancer cells.
    Steinmetz R; Young PC; Caperell-Grant A; Gize EA; Madhukar BV; Ben-Jonathan N; Bigsby RM
    Cancer Res; 1996 Dec; 56(23):5403-9. PubMed ID: 8968093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered expression of estrogen-regulated genes in a tamoxifen-resistant and ICI 164,384 and ICI 182,780 sensitive human breast cancer cell line, MCF-7/TAMR-1.
    Lykkesfeldt AE; Madsen MW; Briand P
    Cancer Res; 1994 Mar; 54(6):1587-95. PubMed ID: 8137264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Models of estrogen receptor regulation by estrogens and antiestrogens in breast cancer cell lines.
    Pink JJ; Jordan VC
    Cancer Res; 1996 May; 56(10):2321-30. PubMed ID: 8625307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term hydroxytamoxifen treatment of an MCF-7-derived breast cancer cell line irreversibly inhibits the expression of estrogenic genes through chromatin remodeling.
    Badia E; Duchesne MJ; Semlali A; Fuentes M; Giamarchi C; Richard-Foy H; Nicolas JC; Pons M
    Cancer Res; 2000 Aug; 60(15):4130-8. PubMed ID: 10945620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of pS2 gene expression by affinity labeling and reversibly binding estrogens and antiestrogens: comparison of effects on the native gene and on pS2-chloramphenicol acetyltransferase fusion genes transfected into MCF-7 human breast cancer cells.
    Weaver CA; Springer PA; Katzenellenbogen BS
    Mol Endocrinol; 1988 Oct; 2(10):936-45. PubMed ID: 2460749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of antiestrogens on pS2 and cathepsin D mRNA induction in MCF-7 breast cancer cells.
    Rajah TT; Dunn ST; Pento JT
    Anticancer Res; 1996; 16(2):837-42. PubMed ID: 8687138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1alpha,25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells.
    Swami S; Krishnan AV; Feldman D
    Clin Cancer Res; 2000 Aug; 6(8):3371-9. PubMed ID: 10955825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthetic antiestrogens modulate induction of pS2 and cathepsin-D messenger ribonucleic acid by growth factors and adenosine 3',5'-monophosphate in MCF7 cells.
    Chalbos D; Philips A; Galtier F; Rochefort H
    Endocrinology; 1993 Aug; 133(2):571-6. PubMed ID: 8344199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of human estrogen receptor using an efficient adenoviral gene delivery system is able to restore hormone-dependent features to estrogen receptor-negative breast carcinoma cells.
    Lazennec G; Katzenellenbogen BS
    Mol Cell Endocrinol; 1999 Mar; 149(1-2):93-105. PubMed ID: 10375022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 9-Cis retinoic acid inhibits growth of breast cancer cells and down-regulates estrogen receptor RNA and protein.
    Rubin M; Fenig E; Rosenauer A; Menendez-Botet C; Achkar C; Bentel JM; Yahalom J; Mendelsohn J; Miller WH
    Cancer Res; 1994 Dec; 54(24):6549-56. PubMed ID: 7987855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-proliferative and anti-estrogenic effects of ICI 164,384 and ICI 182,780 in 4-OH-tamoxifen-resistant human breast-cancer cells.
    Coopman P; Garcia M; Brünner N; Derocq D; Clarke R; Rochefort H
    Int J Cancer; 1994 Jan; 56(2):295-300. PubMed ID: 8314314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of interferon regulatory factor-1, nucleophosmin, nuclear factor-kappaB, and cyclic AMP response element binding with acquired resistance to Faslodex (ICI 182,780).
    Gu Z; Lee RY; Skaar TC; Bouker KB; Welch JN; Lu J; Liu A; Zhu Y; Davis N; Leonessa F; Brünner N; Wang Y; Clarke R
    Cancer Res; 2002 Jun; 62(12):3428-37. PubMed ID: 12067985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The AF-2 region of the retinoic acid receptor alpha mediates retinoic acid inhibition of estrogen receptor function in breast cancer cells.
    Pratt MA; Deonarine D; Teixeira C; Novosad D; Tate BF; Grippo JF
    J Biol Chem; 1996 Aug; 271(34):20346-52. PubMed ID: 8702769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct effects of gonadotropin-releasing hormone analogs and 4-hydroxytamoxifen on pS2 mRNA expression with respect to cell proliferation in MCF-7 breast cancer cells.
    Neri C; Colomb E; Roux-Dosseto M; Martin PM
    Anticancer Res; 1991; 11(1):411-5. PubMed ID: 1826824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of a novel factor, com1, is regulated by 1,25-dihydroxyvitamin D3 in breast cancer cells.
    Bratland A; Risberg K; Maelandsmo GM; Gützkow KB; Olsen OE; Moghaddam A; Wang MY; Hansen CM; Blomhoff HK; Berg JP; Fodstad O; Ree AH
    Cancer Res; 2000 Oct; 60(19):5578-83. PubMed ID: 11034106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of estrogen independence of ZR-75-1 human breast cancer cells by epigenetic alterations.
    van Agthoven T; van Agthoven TL; Dekker A; Foekens JA; Dorssers LC
    Mol Endocrinol; 1994 Nov; 8(11):1474-83. PubMed ID: 7533260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of retinoic acid on proliferation of estrogen-responsive transformed murine Leydig cells in serum-free culture.
    Hirose T; Koga M; Kouhara H; Kishimoto S; Matsumoto K; Sato B
    Cancer Res; 1990 Aug; 50(16):5060-4. PubMed ID: 2165854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estradiol-induced vascular endothelial growth factor-A expression in breast tumor cells is biphasic and regulated by estrogen receptor-alpha dependent pathway.
    Sengupta K; Banerjee S; Saxena N; Banerjee SK
    Int J Oncol; 2003 Mar; 22(3):609-14. PubMed ID: 12579315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of growth inhibitory effects of retinoic acid in human breast cancer cells following long-term exposure to retinoic acid.
    Stephen R; Darbre PD
    Br J Cancer; 2000 Nov; 83(9):1183-91. PubMed ID: 11027432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.